Stephanie Tuminello | Genetic Epidemiology | Innovative Research Award

 

Innovative Research Award

Stephanie Tuminello
Icahn School of Medicine at Mount Sinai

Stephanie Tuminello
Affiliation Icahn School of Medicine at Mount Sinai
Country United States
Scopus ID 57193871243
Documents 60
Citations 1,069
h-index 15
Subject Area Genetic Epidemiology
Event Global Genetics Awards

Stephanie Tuminello is affiliated with the Icahn School of Medicine at Mount Sinai, where her scholarly work contributes to the advancement of genetic epidemiology and related biomedical research. Her publication record, citation performance, and sustained research activity demonstrate continued engagement in understanding genetic determinants of disease, epidemiological methodologies, and translational biomedical science. Bibliometric indicators from Scopus show a substantial scholarly contribution supported by peer-reviewed publications and academic citations, reflecting the influence of her research within the international scientific community.[1]

Abstract

Stephanie Tuminello’s research portfolio focuses on genetic epidemiology through the integration of population-based investigation, molecular genetics, and clinical data analysis. Her scientific work contributes to understanding disease susceptibility, inherited genetic variation, and risk prediction using evidence-based epidemiological methodologies. The body of published literature demonstrates interdisciplinary collaboration and continued scientific productivity across multiple areas of biomedical research.[1]

Keywords

Genetic Epidemiology; Population Genetics; Human Genetics; Disease Susceptibility; Precision Medicine; Genomic Medicine; Epidemiological Research; Translational Medicine.

Introduction

Genetic epidemiology combines principles from genetics, epidemiology, and biostatistics to evaluate inherited and environmental influences on disease occurrence. Researchers working within this discipline investigate genetic risk factors, gene-environment interactions, and population-level disease patterns to improve healthcare outcomes. Stephanie Tuminello’s scholarly activities align with these objectives through peer-reviewed research that contributes to the broader understanding of genetic determinants of human health.[2]

Research Profile

According to publicly available bibliometric information, Stephanie Tuminello has authored 60 indexed publications that have collectively received more than one thousand citations, resulting in an h-index of 15. These indicators suggest sustained scholarly productivity and measurable research influence within biomedical sciences and genetic epidemiology.[1]

  • Affiliation: Icahn School of Medicine at Mount Sinai
  • Primary discipline: Genetic Epidemiology
  • Scopus-indexed publications: 60
  • Scopus citations: 1,069
  • Scopus h-index: 15

Research Contributions

The available publication record indicates contributions involving genetic risk assessment, epidemiological analysis, disease association studies, clinical research methodologies, and collaborative biomedical investigations. Such work supports improved understanding of disease mechanisms and facilitates evidence generation for future precision medicine initiatives.[1][3]

  • Population-based genetic investigations.
  • Clinical and translational epidemiological research.
  • Genetic susceptibility and disease association studies.
  • Interdisciplinary collaboration across biomedical sciences.

Publications

The author’s publication portfolio consists of peer-reviewed journal articles indexed by major scholarly databases. These publications collectively address topics within genetics, epidemiology, biomedical science, and translational research, demonstrating continued scientific productivity over multiple years.[1]

  • Research articles indexed in Scopus.
  • Collaborative multidisciplinary publications.
  • Biomedical and genetic epidemiology studies.

Research Impact

Bibliometric evidence indicates measurable academic influence through citations, publication output, and scholarly visibility. Citation metrics suggest that the published work has contributed to ongoing scientific discussions and has been referenced by researchers working in related biomedical disciplines. Such indicators are commonly employed in evaluating scientific productivity and research influence.[1]

Award Suitability

Stephanie Tuminello demonstrates characteristics generally considered during evaluation for an Innovative Research Award, including sustained publication activity, measurable citation impact, interdisciplinary collaboration, and contributions to genetic epidemiology. Recognition within an academic awards program would appropriately acknowledge continued scientific engagement while reflecting objective scholarly indicators rather than subjective assessments of scientific merit alone.[1]

Conclusion

Stephanie Tuminello has established an active academic profile through contributions to genetic epidemiology, peer-reviewed publications, and collaborative biomedical research. Publicly available bibliometric indicators demonstrate sustained scholarly productivity and research visibility, supporting recognition within academic and professional award programs dedicated to scientific excellence and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Stephanie Tuminello, Author ID 57193871243.
    Scopus.https://www.scopus.com/authid/detail.uri?authorId=57193871243
  2. Disparities in COVID-19 testing and positivity in New York City
    https://www.sciencedirect.com/science/article/pii/S0749379720302634
  3. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
    https://www.nature.com/articles/ncomms14922
  4. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City
    https://journal.chestnet.org/article/S0012-3692(20)34288-4/fulltext
  5. The impact of asthma on mortality in patients with COVID-19
    https://journal.chestnet.org/article/S0012-3692(20)31645-7/fulltext

 

Wei Li | Gene Therapy | Research Excellence Award

Prof. Dr. Wei Li | Gene Therapy | Research Excellence Award

Department of Hematology, the First Affiliated Hospital of Zhengzhou University | China

Dr. Wei Li is an Associate Professor and Lab Director at the Department of Hematology, the First Affiliated Hospital of Zhengzhou University. He holds a PhD in Bioinformatics and completed postdoctoral training in clinical medicine. His research centers on erythroid development, hematological malignancies, and disease genomics, with a strong emphasis on genetic mechanisms underlying red cell disorders and cancer. Dr. Li has published 17 peer-reviewed articles in leading journals such as Blood and Journal of Hematology & Oncology, and has an H-index of 22. He leads multiple national research projects, serves as Associate Editor of the Journal of Translational Medicine, and maintains international collaborations, notably with the New York Blood Center.

Citation Metrics (Scopus)

3000
2000
1000
100
0

Citations
1,394

Documents
63

h-index
21

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile

Featured Publications

Rui Xiao | Molecular Genetics | Editorial Board Member

Prof. Rui Xiao | Molecular Genetics | Editorial Board Member

Inner Mongolia Medical University | China

Rui Xiao is a Professor and Director of the Key Laboratory of Molecular Pathology at Inner Mongolia Medical University, China. With a Ph.D. in Animal Biotechnology from Konkuk University, South Korea, he has built a distinguished academic career focusing on gene functions and molecular mechanisms of major diseases. He has led over 30 funded research projects and published more than 100 scientific papers, along with contributing to books and holding multiple patents. Professor Xiao actively serves in several scientific societies and as an expert reviewer for national programs. His contributions have earned him numerous awards and recognitions, highlighting his impact in biomedical research and education.

Citation Metrics (Scopus)

300
200
100
10
0

Citations
165

Documents
23

h-index
6

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile

Featured Publications

Abdul Karim Khalid | Host Genetics | Best Paper Award

Mr. Abdul Karim Khalid | Host Genetics | Best Paper Award

Huazhong Agricultural University | China

Abdul Karim Khalid is a veterinary researcher specializing in preventive veterinary medicine, microbial pathogenesis, and host–microbe interactions, currently based in Wuhan, China. He earned his Master’s degree in Preventive Veterinary Medicine from Huazhong Agricultural University with a strong academic record, where his thesis focused on elucidating the role of the secreted protein MbovP537 as a virulence factor and diagnostic antigen in Mycoplasma bovis pathogenesis. His research integrates molecular microbiology, immunology, and translational One Health approaches, encompassing gene cloning, protein expression, mammalian cell culture, and advanced immunological assays. Abdul has contributed to multiple high-impact peer-reviewed publications in journals such as Veterinary Microbiology, eLife, Cells, and Frontiers in Immunology. He also holds a Doctor of Veterinary Medicine degree from Gomal University, Pakistan, and brings valuable clinical experience alongside strong bioinformatics and statistical analysis skills.

Citation Metrics (Scopus)

30
20
10
5
0

Citations
6

Documents
3

h-index
2

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile
View GoogleScholar Profile

Jaina Razbek | Epidemiology | Best Scholar Award

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022